Mr. Rousseau was named President, Cardiovascular and Neuromodulation for Abbott upon the January 2017 close of the Abbott acquisition of St. Jude Medical, where Mr. Rousseau held the role of President and Chief Executive Officer. He joined St. Jude Medical in 1999 and held progressive leadership roles throughout his tenure, driving strategic growth and transformation in fast-growing areas such as atrial fibrillation, heart failure, structural heart and chronic pain.
Prior to his time at St. Jude Medical, Mr. Rousseau worked for Sulzer Intermedics, Inc. for over 10 years, leading various functional areas. Mr. Rousseau received his B.B.A. degree in business administration with an emphasis on risk management and insurance from the University of Georgia.